Abstract:Helios, a transcription factor encoded by IKZF2 of the Ikaros transcription factor family, has an important role in regulating adaptive immune response, not only in regulatory T cells but also in effector T cells. Insights from patients with IKZF2 mutations and translational research in healthy individuals underscore how loss of Helios disrupts immune balance, contributing to pro‐inflammatory T cell phenotypes, dysregulated germinal centre reaction, and premature immune senescence. As drugs targeting Helios enter clinical trials, this review synthesizes evidence from both human and murine studies to highlight its impact on sustaining lymphocyte self‐control. Transcription factor Helios, encoded by the IKZF2 gene, has an important role in regulatory T cells by stabilizing their suppressive phenotype. While Helios is prominently expressed in regulatory T cells, its expression extends beyond to include effector T cells, follicular regulatory T cells, B cells, and innate‐like lymphocyte populations. Recent characterizations of patients with inborn error of immunity due to damaging IKZF2 variants coupled with translational research on lymphocytes from healthy individuals, have increased our understanding on Helios' multifaceted role in controlling the human adaptive immune system. A less studied role for Helios beyond the stabilizing of regulatory T cells has emerged in directing effector T cell maturation. In the absence of functional Helios, effector T cells acquire more inflammatory phenotype and are prone to senescence. Loss of Helios expression disrupts the regulation of the germinal centre reaction, often resulting in either hypogammaglobulinemia or B cell autoimmunity. This review summarizes findings from studies in both mice and men offering a comprehensive understanding of the impact of the transcription factor Helios on the adaptive immune system.

IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function

[Role and Significance of Ikaros Family in the Development of Hematopoietic System -Review].

Ikaros is a principal regulator of Aire + mTEC homeostasis, thymic mimetic cell diversity, and central tolerance

Helios—Illuminating the way for lymphocyte self‐control

T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch

IKAROS and AIOLOS directly regulate AP-1 transcriptional complexes and are essential for NK cell development

Evolution of the Ikaros family transcription factors: From a deuterostome ancestor to humans

Foxp3 depends on Ikaros for control of regulatory T cell gene expression and function

Multifaceted roles of IKZF1 gene, perspectives from bench to bedside

Expression Characteristics of Isoforms of Ikaros and Helios in Patients with Leukemia and Their Mechanism

The role of ThPOK in T cell differentiation and development

Serine Phosphorylation by SYK is Critical for Nuclear Localization and Transcription Factor Function of Ikaros

Conserved helical motifs in the Ikaros IDR mediate NuRD interaction and transcriptional repression

Helios, a Novel Dimerization Partner of Ikaros Expressed in the Earliest Hematopoietic Progenitors.

Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation

Ikaros Proteins in Tumor: Current Perspectives and New Developments

Ikaros antagonizes DNA binding by STAT5 in pre-B cells

Critical roles of Ikaros and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia

Regulatory Phosphorylation of Ikaros by Bruton's Tyrosine Kinase

The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes